Sporimune™ (cyclosporine capsules) USP MODIFIED
Sporimune™ (cyclosporine capsules) USP MODIFIED 25mg
Sporimune™ (cyclosporine capsules) USP MODIFIED 50mg
Sporimune™ (cyclosporine capsules) USP MODIFIED 100mg
Sporimune™ is indicated for the control of atopic dermatitis in dogs weighing at least 4 lbs. (1.8 kg) body weight.
Important safety information
As with all drugs, side effects may occur. Do not use Sporimune™ in dogs with a history of neoplasia, reproducing dogs, or dogs with a hypersensitivity to cyclosporine. Sporimune is a systemic immunosuppressant that may increase the susceptibility to infection and the development of neoplasia. For use only in dogs. Keep this and all drugs out of reach of children. Capsules should not be broken or opened. Wear gloves during administration and wash hands after. Gastrointestinal problems and gingival hyperplasia may occur at the initial recommended dose. Safety and effectiveness have not been established in dogs less than 6 months or 4 lbs. Use with caution in dogs with diabetes mellitus or renal insufficiency, and with drugs that affect the P-450 enzyme system. Killed vaccines are recommended. The most common adverse events are vomiting and diarrhea. Refer to the product insert for full prescribing information or visit www.dechra-us.com.
Sporimune is a trademark of Dechra Veterinary Products, LLC.